Document is current
Any future updates will be listed below
-
Authors
Suzuki, Kazuhiro http://orcid.org/0000-0002-0038-4329
Yamasaki, Syudo
Miyashita, Mitsuhiro http://orcid.org/0000-0002-7798-1834
Ando, Shuntaro
Toriumi, Kazuya http://orcid.org/0000-0002-8593-3269
Yoshikawa, Akane
Nakanishi, Miharu http://orcid.org/0000-0001-6200-9279
Morimoto, Yuko
Kanata, Sho
Fujikawa, Shinya
Endo, Kaori http://orcid.org/0000-0003-0854-5120
Koike, Shinsuke http://orcid.org/0000-0002-3375-236X
Usami, Satoshi
Itokawa, Masanari
Washizuka, Shinsuke
Hiraiwa-Hasegawa, Mariko
Meltzer, Herbert Y. http://orcid.org/0000-0003-4901-8845
Kasai, Kiyoto http://orcid.org/0000-0002-4443-4535
Nishida, Atsushi
Arai, Makoto http://orcid.org/0000-0003-3400-9815
- License Information
-
More Information
Article History
Received: 21 November 2021
Accepted: 21 March 2022
First Online: 27 April 2022
Competing interests
: K.S., S.Y., M.M., S.A., K.K., A.N., and M.A. received grant support from the Japan Society for the Promotion of Science during the conduct of the study. M.M., M.I., and M.A. have a patent (PCT/JP2008/063803) with royalties paid to Kowa Co. Ltd., outside the submitted work. KK received grant support from MSD, Astellas, Sumitomo Dainippon Pharma, Eisai, Lily, Takeda, and Mitsubishi Tanabe Pharma. K.K. reports personal fees from Daiichi Sankyo, Otsuka, Meiji Seika Pharma, MSD, Yoshitomi, Astellas, Mochida, Sumitomo Dainippon, Eisai, and Fuji-Film RI Pharma outside the submitted work. M.A. received grant support from the Uehara Memorial Foundation, the Sumitomo Foundation, and the SENSHIN Medical Research Foundation. H.Y.M. received grant support from ACADIA, Allergan, Eli Lilly, Janssen, Quincy Pharmaceutical, Sumitomo Dainippon, and Sunovion. H.Y.M. is a stockholder of ACADIA. The remaining authors declare no competing interests.
